about
Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetesRoux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiotaExaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.Effects of Roux-en-Y gastric bypass on fasting and postprandial levels of the inflammatory markers YKL-40 and MCP-1 in patients with type 2 diabetes and glucose tolerant subjects.Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass.Exaggerated release and preserved insulinotropic action of glucagon-like peptide-1 underlie insulin hypersecretion in glucose-tolerant individuals after Roux-en-Y gastric bypass.Reduction in cardiovascular risk factors and insulin dose, but no beta-cell regeneration 1 year after Roux-en-Y gastric bypass in an obese patient with type 1 diabetes: a case report.Increased hepatic insulin clearance after Roux-en-Y gastric bypass.The corticosteroid hormone induced factor: a new modulator of KCNQ1 channels?Circulating Glucagon 1-61 Regulates Blood Glucose by Increasing Insulin Secretion and Hepatic Glucose Production.Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass.Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.Variable reliability of surrogate measures of insulin sensitivity after Roux-en-Y gastric bypass.Systems Signatures Reveal Unique Remission-path of Type 2 Diabetes Following Roux-en-Y Gastric Bypass Surgery.Effects of gastric bypass surgery on glucose absorption and metabolism during a mixed meal in glucose-tolerant individuals.Improvements in glucose metabolism early after gastric bypass surgery are not explained by increases in total bile acids and fibroblast growth factor 19 concentrations.Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery.No Islet Cell Hyperfunction, but Altered Gut-Islet Regulation and Postprandial Hypoglycemia in Glucose-Tolerant Patients 3 Years After Gastric Bypass Surgery.Mechanisms in bariatric surgery: Gut hormones, diabetes resolution, and weight loss.Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgeryAccelerated protein digestion and amino acid absorption after Roux-en-Y gastric bypassFast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypassGastric bypass and duodenal and gastric feeding: a comment to Hansen et alSpecificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studiesPlasma Proteome Profiling Reveals Dynamics of Inflammatory and Lipid Homeostasis Markers after Roux-En-Y Gastric Bypass SurgerySustained Improvements in Glucose Metabolism Late After Roux-En-Y Gastric Bypass Surgery in Patients with and Without Preoperative DiabetesEffect of bariatric surgery on plasma GDF15 in humansEMPA-REG: Glucose excretion and lipid mobilization - not storage - saves lives
P50
Q35165204-237FA017-15ED-426E-8A9C-72665D370D0DQ36053361-FFD25C95-4845-41C8-8653-E3ABF18CC20FQ37110621-7AD1728F-D650-4399-8DDD-4A8C7AC6EA2BQ37330377-F6B915E0-A0D1-4684-A580-91AF30E42BA7Q42449157-8122B616-6AF9-40F0-8FA6-D9499BF09602Q43725442-2DCF0FFA-30FB-4B97-A060-A55113B101E2Q44412675-2B33326D-372B-4C7E-879F-C5BAA78B3D77Q44881659-2E565B66-574C-4939-A751-5DB43FC7A2EFQ46942904-E05D743A-C218-4407-960D-2E2F1D909C70Q47115664-90FC850E-5CB6-4013-A903-91D3F88BBA2FQ47253610-BB1E6C05-AA8E-4036-B29B-BC836C7C049DQ48231744-353FB670-6B09-4405-A8E4-829C2DEAD4ACQ48233068-4565F4A9-2ADE-461B-9607-451CF4DE7BEBQ50052704-4F962A32-011C-4F6C-B012-C2FD99274810Q50788463-D9D82D36-0065-48E7-A12E-71212028F19FQ51310555-2A2CC0B0-1233-41D0-8E8C-1D11B1A5494AQ51357717-F36DEA99-75F1-44C3-A004-DB5DF3889CA6Q53589377-98E4AA0B-0057-4449-9486-56C225792A9FQ53787715-2327F5D2-2513-43B4-B3A4-74281D72852FQ55081525-C778070D-DC4A-42ED-849F-74D8E0FEB618Q58167278-2926CE88-3118-4D27-8374-9570D350F4C6Q58167384-9724BA32-F851-4FF0-A4A6-5B10884C0C72Q58167703-11FBC844-2313-49C1-9902-074EE82A588FQ58167870-0C431DE1-9647-4C22-A819-054DEC410FA1Q58447614-DFC1E01C-BE10-47BA-9EC0-661E6D792CD3Q63379409-A8A9122B-5565-4E06-9E02-E3873FF06911Q90884287-640B5F68-887E-4307-A4E5-F03880020ABCQ91351053-81A3E7FB-6285-4AD0-AFB1-3871B8395030Q95561188-0AEAF196-817E-4034-BAEA-B53728A672CD
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Nils B Jørgensen
@ast
Nils B Jørgensen
@en
Nils B Jørgensen
@es
Nils B Jørgensen
@nl
Nils B Jørgensen
@sl
type
label
Nils B Jørgensen
@ast
Nils B Jørgensen
@en
Nils B Jørgensen
@es
Nils B Jørgensen
@nl
Nils B Jørgensen
@sl
prefLabel
Nils B Jørgensen
@ast
Nils B Jørgensen
@en
Nils B Jørgensen
@es
Nils B Jørgensen
@nl
Nils B Jørgensen
@sl
P108
P106
P31
P496
0000-0002-5764-6377